Need Help?
Contact Us


The WATCHMAN Implant is an innovative one-time procedure designed to reduce the risk of strokes that originate in the left atrial appendage (LAA). 

The implant is a safe alternative to long-term warfarin therapy which offers comparable stroke risk reduction and enables patients to stop taking warfarin.

RHYTHMIA Mapping System

Interact with the world's most advanced 3D, high definition mapping system, with navigational catheter toolset, and the new generation of high-resolution ablation catheters combining MicroFidelity (MiFi) sensor technology and Total Tip Cooling™ catheter design built on the trusted BLAZER platform.

Activation map image courtesy of Elad Anter, MD, Beth Israel Deaconess Medical Center, Boston, Mass.


After initial hospitalization, 25% of heart failure patients are readmitted within 30 days.11-13  The HeartLogic Heart Failure Diagnostic Service may help change that. A promising step beyond current approaches, HeartLogic is a diagnostic service that includes a composite index monitored over time to deliver alerts of worsening heart failure to clinicians.  


Learn about the MR-conditional EMBLEM S-ICD System including new SMART Pass algorithm and AF monitoring.

EnduraLife-Powered CRT-Ds

Only EnduraLife Battery technology has 9 clinical studies, over 8 years of real-world data... and now a recommendation from UK’s National Institute for Health and Care Excellence (NICE).1-10

Medtronic cannot say this. Neither can St. Jude Medical (Abbott).

ACUITY X4 Quadripolar LV Leads

The first and only LV leads uniquely designed to promote non-apical pacing options, helping physicians to pace from an optimal site for improved CRT response.

ImageReady MR–Conditional Systems

Explore the entire portfolio of ImageReady MR-Conditional products available world-wide from Boston Scientific.

LATITUDE NXT Remote Monitoring System

See how the entire LATITUDE NXT Remote Patient Management system and LATITUDE Consult System fluidly merges the tools and data from Boston Scientific’s trusted LATITUDE platform to give you faster, more efficient remote patient monitoring options with rapid diagnostic data plus 24/7 access to Boston Scientific’s technical analysis and expertise.

The S-ICD Post-market Approval Study

Michael Gold, MD PhD FHRS

Thursday, May 11

Meet us at 8:00 am, Room 375E

WATCHMAN EWOLUTION Late Breaking Clinical Trial

Lucas VA Boermsa, MD PhD

Friday, May 12

Meet us at 11:00 am, Room 375E

Rhythm Theatre

Join us May 11th at 9:35 am in Rhythm Theatre 2 for a discussion on patient-specific approaches to maximizing CRT therapy with SMARTCRT and HEARTLOGIC.



Receive emails on the latest news from Boston Scientific.